Mice Model Market: By Type (Inbred Mice, Genetically Engineered Mice, Conditioned/Surgically Modified Mice, Hybrid/Congenic Mice, Outbred Mice and Spontaneous Mutant Mice), By Technology (CRISPR, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer and Other Technologies), By Application (Oncology Studies, Immunology and Inflammation Studies, Diabetes Studies, Cardiovascular Studies, Central Nervous System Studies and Other Diseases), By Service (Breeding Services, Cryopreservation, Quarantine, Rederivation, Genetic Testing, Model in licensing and Other Services) and Geography  

Mice Model Market size was valued at USD 2.8 billion in 2022 and is poised to grow at a CAGR of 6.6% from 2023-29. A lot of research on human health and disorders is done with mice models. Mice models come in a variety of forms, including inbred, genetically modified, hybrid/congenic, and conditioned/surgically altered mice. Numerous fields, including genetics, oncology, cardiology, and endocrine and metabolic research, can make use of these models. Inbred mice were necessary animal models for logical research during the twentieth century and will give crucial results in the current and subsequent centuries. They offer very functional animal models with obvious advantages when compared with outbred, that is, highly variable, populations.  Because mice models are essential to the development of personalized medicines, their market value is rising in tandem with the growing need for personalized medicine. Pre-clinical trials employ mice models to investigate the safety and effectiveness of medications, assisting in the determination of the appropriate dosage and course of treatment for a certain patient. The need for mice models is predicted to increase as customized treatment becomes increasingly common.